France
· Delayed Price · Currency is EUR Aelis Farma Statistics
Total Valuation
Aelis Farma has a market cap or net worth of EUR 155.39 million. The enterprise value is 139.20 million.
| Market Cap | 155.39M |
| Enterprise Value | 139.20M |
Important Dates
The next estimated earnings date is Monday, September 16, 2024.
| Earnings Date | Sep 16, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Aelis Farma has 13.63 million shares outstanding.
| Shares Outstanding | 13.63M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 38.24% |
| Owned by Institutions (%) | 0.43% |
| Float | 3.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 5.62 |
| PS Ratio | 11.90 |
| PB Ratio | 11.38 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -27.41 |
| EV / Sales | 11.26 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -10.67 |
Financial Position
The company has a current ratio of 2.48, with a Debt / Equity ratio of 30.60.
| Current Ratio | 2.48 |
| Quick Ratio | 2.37 |
| Debt / Equity | 30.60 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.31 |
| Interest Coverage | -41.17 |
Financial Efficiency
Return on equity (ROE) is -30.78% and return on invested capital (ROIC) is -19.77%.
| Return on Equity (ROE) | -30.78% |
| Return on Assets (ROA) | -12.33% |
| Return on Capital (ROIC) | -19.77% |
| Revenue Per Employee | 475,308 |
| Profits Per Employee | -195,308 |
| Employee Count | 26 |
| Asset Turnover | 0.38 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.39% in the last 52 weeks. The beta is 0.11, so Aelis Farma's price volatility has been lower than the market average.
| Beta (5Y) | 0.11 |
| 52-Week Price Change | -17.39% |
| 50-Day Moving Average | 11.94 |
| 200-Day Moving Average | 12.91 |
| Relative Strength Index (RSI) | 30.98 |
| Average Volume (20 Days) | 167 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Aelis Farma had revenue of EUR 12.36 million and -5.08 million in losses. Loss per share was -0.39.
| Revenue | 12.36M |
| Gross Profit | 12.36M |
| Operating Income | -6.46M |
| Pretax Income | -5.08M |
| Net Income | -5.08M |
| EBITDA | -6.40M |
| EBIT | -6.46M |
| Loss Per Share | -0.39 |
Balance Sheet
The company has 20.23 million in cash and 4.04 million in debt, giving a net cash position of 16.19 million or 1.19 per share.
| Cash & Cash Equivalents | 20.23M |
| Total Debt | 4.04M |
| Net Cash | 16.19M |
| Net Cash Per Share | 1.19 |
| Equity (Book Value) | 13.20M |
| Book Value Per Share | 1.00 |
| Working Capital | 14.84M |
Cash Flow
In the last 12 months, operating cash flow was -12.96 million and capital expenditures -88,000, giving a free cash flow of -13.05 million.
| Operating Cash Flow | -12.96M |
| Capital Expenditures | -88,000 |
| Free Cash Flow | -13.05M |
| FCF Per Share | -0.96 |
Margins
Gross margin is 100.00%, with operating and profit margins of -52.30% and -41.09%.
| Gross Margin | 100.00% |
| Operating Margin | -52.30% |
| Pretax Margin | -41.07% |
| Profit Margin | -41.09% |
| EBITDA Margin | -51.80% |
| EBIT Margin | -52.30% |
| FCF Margin | -105.58% |
Dividends & Yields
Aelis Farma does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -3.45% |
| FCF Yield | -8.40% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |